-
公开(公告)号：WO2007017720A1
公开(公告)日：2007-02-15
申请号：PCT/IB2006/002098
申请日：2006-08-02
Applicant: GLENMARK PHARMACEUTICALS LIMITED , KUMAR, Bobba, Venkata, Siva , PATEL, Girish, Bansilal , KALE, Sanjay, Anantha , PRADHAN, Nitin, S.
Inventor： KUMAR, Bobba, Venkata, Siva , PATEL, Girish, Bansilal , KALE, Sanjay, Anantha , PRADHAN, Nitin, S.
Abstract: A process for the preparation of substantially pure acitretin of Formula (I) is provided: the process comprising (a) contacting a salt of acitretin with one or more solvents; and (b) isolating substantially pure acitretin from the product of step (a).
Abstract translation: 提供了制备基本上纯的阿维A酸的方法，该方法包括：（a）将阿曲酸的盐与一种或多种溶剂接触; 和（b）从步骤（a）的产物中分离出基本上纯的阿曲汀。
-
2.发明申请PROCESSES FOR THE PREPARATION OF ALFUZOSIN AND SALTS THEREOF AND NOVEL CRYSTALLINE FORMS OF ALFUZOSIN 审中-公开制备ALFUZOSIN及其盐的方法和ALFUZOSIN的新型结晶形式
公开(公告)号：WO2006090268A3
公开(公告)日：2006-10-26
申请号：PCT/IB2006000431
申请日：2006-02-28
Applicant: GLENMARK PHARMACEUTICALS LTD , JOSHI NARENDRA SHRIRAM , RAMAM BUDDHAVARAPU PATTABHI , RAO KODALI ESWARA , BHIRUD SHEKHAR BHASKAR , PRADHAN NITIN S
Inventor： JOSHI NARENDRA SHRIRAM , RAMAM BUDDHAVARAPU PATTABHI , RAO KODALI ESWARA , BHIRUD SHEKHAR BHASKAR , PRADHAN NITIN S
IPC: C07D405/12 , A61K31/505
CPC classification number: C07D405/12
Abstract: The present invention provides novel crystalline forms of a.lfuzosin and alfuzosin hydrochloride and processes for their preparation. Also provided are pharmaceutical compositions containing the new crystalline forms.
Abstract translation: 本发明提供了福佐沙星和盐酸阿夫唑嗪的新型结晶形式及其制备方法。 还提供含有新结晶形式的药物组合物。
-
Patent Agency Ranking
公开(公告)号：WO2007020527A3
公开(公告)日：2007-02-22
申请号：PCT/IB2006/002247
申请日：2006-08-18
Applicant: GLENMARK PHARMACEUTICALS LIMITED , KUMAR, B.V. Siva , SRINIVAS, Kosampally , KALE, Sanjay, Anantha , PRADHAN, Nitin, S.
Inventor： KUMAR, B.V. Siva , SRINIVAS, Kosampally , KALE, Sanjay, Anantha , PRADHAN, Nitin, S.
IPC: C07D333/38 , A61K31/381 , A61P19/08
Abstract: A process for the preparation of strontium ranelate or a hydrate thereof is provided comprising (a) reacting a tetraester compound of Formula II: wherein R, R 1 , R 2 , and R 3 are independently a linear or branched C 1 -C 6 alkyl group or a substituted or unsubstituted C 3 -C 12 cyclic group, in the presence of a lithium base and in a solvent with an inorganic acid salt of strontium.
-
4.发明申请SUBSTANTIALLY PURE MICRONIZED PARTICLES OF TELMISARTAN AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME 审中-公开特拉西坦和含有其的药物组合物的大量纯化微球
公开(公告)号：WO2006136916A3
公开(公告)日：2007-05-18
申请号：PCT/IB2006001663
申请日：2006-06-20
Applicant: GLENMARK PHARMACEUTICALS LTD , JOSHI NARENDRA SHRIRAM , RAO KODALI ESWARA , PRADHAN NITIN S
Inventor： JOSHI NARENDRA SHRIRAM , RAO KODALI ESWARA , PRADHAN NITIN S
IPC: A61K9/14 , A61K31/4184
CPC classification number: A61K31/4184 , A61K9/1688
Abstract: The present invention provides micronized particles of substantially pure telmisartan or a pharmaceutically acceptable salt, ester or derivative thereof. Also provided are pharmaceutical compositions containing the micronized particles of substantially pure telmisartan or a pharmaceutically acceptable salt, ester or derivative thereof.
Abstract translation: 本发明提供基本上纯的替米沙坦或其药学上可接受的盐，酯或衍生物的微粉化颗粒。 还提供了含有基本上纯的替米沙坦或其药学上可接受的盐，酯或衍生物的微粉化颗粒的药物组合物。
-
公开(公告)号：WO2007020527A2
公开(公告)日：2007-02-22
申请号：PCT/IB2006002247
申请日：2006-08-18
Applicant: GLENMARK PHARMACEUTICALS LTD , KUMAR B V SIVA , SRINIVAS KOSAMPALLY , KALE SANJAY ANANTHA , PRADHAN NITIN S
Inventor： KUMAR B V SIVA , SRINIVAS KOSAMPALLY , KALE SANJAY ANANTHA , PRADHAN NITIN S
CPC classification number: C07D333/38
Abstract: A process for the preparation of strontium ranelate or a hydrate thereof is provided comprising (a) reacting a tetraester compound of Formula II: wherein R, R 1 , R 2 , and R 3 are independently a linear or branched C 1 -C 6 alkyl group or a substituted or unsubstituted C 3 -C 12 cyclic group, in the presence of a lithium base and in a solvent with an inorganic acid salt of strontium.
Abstract translation: 提供了制备雷奈酸锶或其水合物的方法，其包括（a）使式II的四酯化合物：其中R 1，R 2，R 2和/ R 3独立地是直链或支链C 1 -C 6烷基或取代或未取代的C 3 -C 6烷基， -C 12 - 环基，在锂碱存在下，在溶剂中与锶的无机酸盐反应。
-
6.发明申请PROCESSES FOR THE PREPARATION OF ALFUZOSIN AND SALTS THEREOF AND NOVEL CRYSTALLINE FORMS OF ALFUZOSIN 审中-公开用于制备阿洛夫辛及其盐的新型晶体形式的方法
公开(公告)号：WO2006090268A2
公开(公告)日：2006-08-31
申请号：PCT/IB2006/000431
申请日：2006-02-28
Applicant: GLENMARK PHARMACEUTICALS LIMITED , JOSHI, Narendra, Shriram , RAMAM, Buddhavarapu Pattabhi , RAO, Kodali, Eswara , BHIRUD, Shekhar, Bhaskar , PRADHAN, Nitin, S.
Inventor： JOSHI, Narendra, Shriram , RAMAM, Buddhavarapu Pattabhi , RAO, Kodali, Eswara , BHIRUD, Shekhar, Bhaskar , PRADHAN, Nitin, S.
IPC: C07D405/12 , A61K31/505
CPC classification number: C07D405/12
Abstract: The present invention provides novel crystalline forms of a.lfuzosin and alfuzosin hydrochloride and processes for their preparation. Also provided are pharmaceutical compositions containing the new crystalline forms.
Abstract translation: 本发明提供a.lfuzosin和阿夫唑嗪盐酸盐的新型晶体形式及其制备方法。 还提供了含有新结晶形式的药物组合物。
-
7.发明申请SUBSTANTIALLY PURE MICRONIZED PARTICLES OF TELMISARTAN AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME 审中-公开特拉西坦和含有其的药物组合物的大量纯化微球
公开(公告)号：WO2006136916A2
公开(公告)日：2006-12-28
申请号：PCT/IB2006/001663
申请日：2006-06-20
Applicant: GLENMARK PHARMACEUTICALS LIMITED , JOSHI, Narendra Shriram , RAO, Kodali Eswara , PRADHAN, Nitin S.
Inventor： JOSHI, Narendra Shriram , RAO, Kodali Eswara , PRADHAN, Nitin S.
IPC: A61K9/14 , A61K31/4184
CPC classification number: A61K31/4184 , A61K9/1688
Abstract: The present invention provides micronized particles of substantially pure telmisartan or a pharmaceutically acceptable salt, ester or derivative thereof. Also provided are pharmaceutical compositions containing the micronized particles of substantially pure telmisartan or a pharmaceutically acceptable salt, ester or derivative thereof.
Abstract translation: 本发明提供基本上纯的替米沙坦或其药学上可接受的盐，酯或衍生物的微粉化颗粒。 还提供了含有基本上纯的替米沙坦或其药学上可接受的盐，酯或衍生物的微粉化颗粒的药物组合物。
-
-
-
-
-
-
Search Results
7
records
(took 0.009 seconds)
